These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19258822)

  • 1. Body image and quality of life in men with prostate cancer.
    Harrington JM; Badger TA
    Cancer Nurs; 2009; 32(2):E1-7. PubMed ID: 19258822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body image perceptions in men with prostate cancer.
    Harrington JM; Jones EG; Badger T
    Oncol Nurs Forum; 2009 Mar; 36(2):167-72. PubMed ID: 19273405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
    Hansen PA; Dechet CB; Porucznik CA; LaStayo PC
    PM R; 2009 Nov; 1(11):1019-24. PubMed ID: 19942188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
    Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study.
    Pirl WF; Siegel GI; Goode MJ; Smith MR
    Psychooncology; 2002; 11(6):518-23. PubMed ID: 12476433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer.
    Esper P; Hampton JN; Smith DC; Pienta KJ
    Oncol Nurs Forum; 1999; 26(1):107-12. PubMed ID: 9921573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy.
    Keogh JW; Shepherd D; Krägeloh CU; Ryan C; Masters J; Shepherd G; MacLeod R
    N Z Med J; 2010 Nov; 123(1325):20-9. PubMed ID: 21317957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information needs of men on androgen deprivation therapy.
    Soeyonggo T; Warde P; Fleshner N; Timilshina N; Alibhai SM
    BJU Int; 2012 May; 109(10):1503-9. PubMed ID: 21883845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of treatment on body image and quality of life.
    Harrington JM
    Semin Oncol Nurs; 2011 Nov; 27(4):290-9. PubMed ID: 22018408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.
    Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA
    J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues.
    Gomella LG
    BJU Int; 2007 Jan; 99 Suppl 1():25-9; discussion 30. PubMed ID: 17229166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.
    Alibhai SM; Breunis H; Timilshina N; Johnston C; Tomlinson G; Tannock I; Krahn M; Fleshner NE; Warde P; Canning SD; Klotz L; Naglie G
    J Clin Oncol; 2010 Dec; 28(34):5038-45. PubMed ID: 21041715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.
    Spry NA; Kristjanson L; Hooton B; Hayden L; Neerhut G; Gurney H; Corica T; Korbel E; Weinstein S; McCaul K
    Eur J Cancer; 2006 May; 42(8):1083-92. PubMed ID: 16632343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer.
    Mottet N; Prayer-Galetti T; Hammerer P; Kattan MW; Tunn U
    BJU Int; 2006 Jul; 98(1):20-7. PubMed ID: 16566812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
    Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
    Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
    Saini A; Berruti A; Cracco C; Sguazzotti E; Porpiglia F; Russo L; Bertaglia V; Picci RL; Negro M; Tosco A; Campagna S; Scarpa RM; Dogliotti L; Furlan PM; Ostacoli L
    Urol Oncol; 2013 Apr; 31(3):352-8. PubMed ID: 21803612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE.
    Abouassaly R; Paciorek A; Ryan CJ; Carroll PR; Klein EA
    Cancer; 2009 Oct; 115(19):4470-6. PubMed ID: 19637339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory.
    Steginga SK; Pinnock C; Gardner M; Gardiner RA; Dunn J
    BJU Int; 2005 Jan; 95(1):46-50. PubMed ID: 15663527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body image predicts quality of life in men with prostate cancer.
    Taylor-Ford M; Meyerowitz BE; D'Orazio LM; Christie KM; Gross ME; Agus DB
    Psychooncology; 2013 Apr; 22(4):756-61. PubMed ID: 22422671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.